Ajay Bansal's Net Worth

$313 Thousand

Estimate Recalculated Nov 1, 2024 08:31AM EST

Who is Ajay Bansal

Ajay Bansal does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include COMPLETE GENOMICS INC, TERCICA INC, ViewRay, Inc., LEXICON PHARMACEUTICALS, INC./DE, Urovant Sciences Ltd., Onconova Therapeutics, Inc., and NEKTAR THERAPEUTICS.

SEC CIK

Ajay Bansal's CIK is 0001236922

Past Insider Trading and Trends

2004 was Ajay Bansal's most active year for acquiring shares with 6 total transactions. Ajay Bansal's most active month to acquire stocks was the month of February. 2006 was Ajay Bansal's most active year for disposing of shares, totalling 15 transactions. Ajay Bansal's most active month to dispose stocks was the month of February. 2005 saw Ajay Bansal paying a total of $425,190.00 for 44,166 shares, this is the most they've acquired in one year. In 2008 Ajay Bansal cashed out on 386,000 shares for a total of $2,514,710.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COMPLETE GENOMICS INC

SVP & Chief Financial Officer
Updated Mar 18, 2013
Form 4
-100.00%
-179.70K
$1.73
-$71.22K
Mar 18, 2013
Disposition
Mar 14 - Mar 18
Form 4
50.00K
Apr 04, 2012
50.00K
Grant
Apr 02
Form 4/A
70.00K
Feb 14, 2012
70.00K
Grant
Apr 11
Form 4
-50.00%
-70.00K
Apr 13, 2011
70.00K
Grant
Apr 11
Form 3
Nov 10, 2010
Showing 5 results

TERCICA INC

Chief Financial Officer
Updated Oct 20, 2008
Form 4
-100.00%
-386.00K
$7.60
-$2.51M
Oct 20, 2008
Disposition
Oct 16
Form 4
2,366.67%
71.00K
Mar 27, 2008
74.00K
Grant
Mar 25
Form 4
85.00K
Feb 15, 2007
85.00K
Grant
Feb 14
Form 4
225.00K
Mar 29, 2006
225.00K
Grant
Mar 28
Form 3
Mar 29, 2006
Showing 5 results

ViewRay, Inc.

Chief Financial Officer
Updated Jul 29, 2019
Form 4
-4.27%
-4.41K
$3.11
-$1.55K
Jul 29, 2019
98.88K
Options
Jul 25
Form 4
80.88%
56.70K
Mar 05, 2019
126.80K
Grant
Mar 01
Form 4
110.00K
Apr 18, 2018
110.00K
Grant
Apr 16
Form 4
50.00K
Feb 23, 2017
50.00K
Grant
Feb 18
Form 4
103.54K
Jan 25, 2017
103.54K
Grant
Jan 23
Form 4
1,000.61%
75.12K
$1.65
$200.00K
Jan 20, 2017
82.62K
Purchase
Jan 18
Form 4
7.51K
Dec 19, 2016
7.51K
Grant
Dec 15
Form 4
59.83K
Sep 15, 2016
59.83K
Grant
Sep 13
Form 4
550.00K
Jun 16, 2016
550.00K
Grant
Jun 14
Form 3
Jun 16, 2016
Showing 10 results

LEXICON PHARMACEUTICALS, INC./DE

EVP Corp Dev and CFO
Updated Jun 02, 2009
Form 4
250.00K
Jun 02, 2009
250.00K
Grant
Jun 02
Form 3
Jun 02, 2009
Showing 2 results

Urovant Sciences Ltd.

See Remarks
Updated Mar 31, 2021
Form 4
-100.00%
-280.10K
Mar 31, 2021
Disposition
Mar 29
Form 4
84.88%
63.66K
May 04, 2020
138.66K
Grant
May 01
Form 4
215.00K
Nov 05, 2019
215.00K
Grant
Nov 05
Form 3
Nov 05, 2019
Showing 4 results

Onconova Therapeutics, Inc.

Chief Financial Officer
Updated Jan 28, 2016
Form 4
69.98K
Jan 28, 2016
69.98K
Grant
Jan 26
Form 4
32.50K
Oct 01, 2015
32.50K
Grant
Sep 25
Form 4
32.50K
Apr 20, 2015
32.50K
Grant
Apr 16
Form 4
65.00K
Dec 22, 2014
65.00K
Grant
Dec 18
Form 4
65.00K
Dec 24, 2013
65.00K
Grant
Dec 20
Form 4
-9.11%
-4.40K
Aug 01, 2013
43.85K
Options
Jul 30
Form 4
45.00K
Jul 29, 2013
45.00K
Grant
Jul 25
Form 3
Jul 24, 2013
20.06K
Showing 8 results

NEKTAR THERAPEUTICS

CFO, VP Finance & Admin
Updated Mar 13, 2006
Form 4
-50.00%
-5.17K
$19.92
-$102.93K
Mar 13, 2006
5.17K
Sale
Mar 10
Form 4
$0.01
Mar 09, 2006
30.83K
Acq/Dis
Mar 08
Form 4
$0.01
Mar 07, 2006
30.83K
Acq/Dis
Mar 03
Form 4
-3.05%
-3.00K
$12.70
-$43.59K
Sep 07, 2005
95.50K
Sale
Sep 07
Form 4
-11.90%
-4.17K
$16.41
-$68.38K
May 17, 2005
30.83K
Sale
May 17
Form 4/A
25.00K
Mar 16, 2005
25.00K
Grant
Mar 01
Form 4
0.86%
30.00K
$9.28
$370.90K
Feb 11, 2005
3.51M
Grant
Feb 09
Form 4
-5.17%
-7.00K
$12.75
-$102.42K
Jan 05, 2005
128.50K
Sale
Jan 03
Form 4/A
25.00K
Dec 07, 2004
25.00K
Grant
Mar 01
Form 4
1.12%
1.50K
$12.72
$38.14K
Dec 01, 2004
135.50K
Sell-Options
Dec 01
Form 4
-1.82%
-3.00K
$13.48
-$50.55K
Mar 08, 2004
162.00K
Sale
Mar 04
Form 4
25.00K
$0.01
$250.00
Mar 03, 2004
25.00K
Grant
Mar 01
Showing 12 results